Abstract:Background: Carcinogenesis is a process in which uncontrolled cell proliferation forms preneoplastic nodules which precede the appearance of cancer. In normal cells, growth and proliferation are regulated by certain growth and hormonal stimulation, while mutational alterations in these signals render the cells independent and resistant to these signals. In cancer, the critical homeostatic balance between cell growth and apoptosis is lost and the cells continue to survive beyond their normal life span. The activation of c-Jun N-terminal kinase (JNK), p38 and caspases are involved in potential proapoptotic signaling pathways. JNK, p38 MAPK pathway and caspases play a crucial role in the control of apoptosis in response to stress. Outline: The most recent and up-to-date literature was evaluated in this study, which describes the role of JNK, p38 MAPK pathway and caspases as therapeutic target in cancer. Chemotherapy uses drugs that are cytotoxic to highly proliferating tumor cells but also kills the non-tumor rapidly proliferating cells in the hair, skin and gastrointestinal tract epithelium, thereby accounting the side effects of these types of treatments. Recently, chemopreventive modalities derived from phytoconstituents present in plants provide a broad-spectrum strategy to overcome the incidence of cancer. Non-toxic, safe and affordable bioavailabilities of chemopreventive agents provide credence support in the field of cancer research compared to conventional therapies that cause serious consequences. Chemoprevention envisages the basic mechanisms like modulating the activity of xenobiotic-metabolizing enzymes, induction of apoptosis, immune system activation, suppressing angiogenesis and the formation of metastasis, antioxidant and anti-inflammatory properties. Conclusion: The present review highlighted the role of phytoconstituents derived from food, vegetables and medicinal plants in the induction of apoptosis in cancer cells, which in turn is mediated by the activation of JNK, p38 MAPK pathways, and caspases.

The Role of JNK in Prostate Cancer Progression and Therapeutic Strategies

Nkx3.1 and P27kip1cooperate in Proliferation Inhibition and Apoptosis Induction in Human Androgen–Independent Prostate Cancer Cells

The Role of the RhoA/Rho Kinase Pathway in Angiogenesis and Its Potential Value in Prostate Cancer (Review).

p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents.

JNK signaling in cancer cell survival

The Role of the Dysregulated JNK Signaling Pathway in the Pathogenesis of Human Diseases and Its Potential Therapeutic Strategies: A Comprehensive Review

The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: a molecular aspect

Selective Inhibitors for JNK Signalling: a Potential Targeted Therapy in Cancer

JNK pathway in osteosarcoma: pathogenesis and therapeutics.

Targeting JNK kinase inhibitors via molecular docking: A promising strategy to address tumorigenesis and drug resistance

JNK Pathway in Osteosarcoma: Pathogenesis and Therapeutics

MAPK/JNK Signalling: a Potential Autophagy Regulation Pathway

Jnk and Pten Cooperatively Control the Development of Invasive Adenocarcinoma of the Prostate

MAPK/JNK signaling: A potential autophagy regulation pathway.

c-Jun N-terminal kinase (JNK), p38, and Caspases: Promising Therapeutic Targets for the Regulation of Apoptosis in Cancer Cells by Phytochemicals

Recent Advances in C-Jun N-Terminal Kinase (JNK) Inhibitors

Mir-137-3p Modulates the Progression of Prostate Cancer by Regulating the JNK3/EZH2 Axis.

The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases

The role of proinflammatory cytokines and CXC chemokines (CXCL1–CXCL16) in the progression of prostate cancer: insights on their therapeutic management

Components of the JNK–MAPK Pathway Play Distinct Roles in Hepatocellular Carcinoma

The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy